Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Low dose hCG plus FSH co-trigger (drug)
• Standard dose of hCG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of California at San Francisco
  San Francisco, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Buseralin (drug) — also listed as: Suprefact
• Placebo (other) — also listed as: normal saline
• pregnyl (drug) — also listed as: hCG

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• TRIO Fertility
  Toronto, Ontario, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Thromboelastometry (diagnostic_test)
• Clotting Studies (diagnostic_test)
• Full Blood Count (diagnostic_test)
• Quantitative hCG (diagnostic_test)
• Pregnancy Test (diagnostic_test)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Chalmers Centre for Sexual and Reproductive Health
  Edinburgh, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Triptorelin acetate (a-GnRH) (drug) — also listed as: Decapeptyl 0.1 mg®
• Ovitrelle® (hCG) (drug)
• Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Instituto Bernabeu
  Palma de Mallorca, Mallorca, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Albacete, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Alicante, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Madrid, Spain
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG (drug)
• Saline Solution (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ayman Shehata Dawood
  Tanta, Algharbia, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG (drug) — also listed as: human chorionic gonadotropin
• Ultrasound (diagnostic_test) — also listed as: transvaginal scan
• Blood test (other) — also listed as: Progesterone, Luteinizing Hormone, Estradiol

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ART Fertility Clinics LLC
  Abu Dhabi, United Arab Emirates
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Duphaston (drug)
• Gonadotropin (drug) — also listed as: Fostimon, Menopure, Menogon, Gonapure
• Cetrotide Injectable Product (drug)
• Decapeptyl (drug)
• Chorionic Gonadotropin (drug) — also listed as: choriomon
• Combined Oral Contraceptive (drug) — also listed as: Gynera
• Cyclo-Progynova (drug)
• progesterone (drug) — also listed as: prontogest

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Elshatby University Maternity Hospital
  Alexandria, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin beta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin beta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alfa (drug) — also listed as: SCH 900962, MK-8962
• recFSH (follitropin beta) (biological) — also listed as: follitropin beta, Puregon®, Follistim®
• gonadatropin releasing hormone (GnRH) antagonist ganirelix (drug)
• human chorion gonadotropin (hCG) (biological)
• progesterone (biological)
• placebo-recFSH (follitropin beta) (drug)
• placebo-corifollitropin alfa (drug)
• open-label recFSH (follitropin beta) (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• corifollitropin alfa (drug) — also listed as: Org 36286
• recFSH (follitropin alfa) (biological) — also listed as: Puregon®/Follistim®
• gonadatropin releasing hormone (GnRH) antagonist ganirelix (drug)
• human chorion gonadatropin (hCG) (drug)
• progesterone (biological)
• placebo-recFSH (follitropin alfa) (drug)
• placebo-corifollitropin alfa (drug)
• open-label recFSH (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• MK-8962 (drug) — also listed as: Corifollitropin alfa
• recFSH (drug) — also listed as: follitropin beta
• Ganirelix (drug) — also listed as: Ganirelix acetate or Ganirelix diacetate
• human Chorionic Gonadotropin (hCG) (drug) — also listed as: human Chorionic Gonadotrophin
• Progesterone (drug) — also listed as: Crinone®

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Low dose hCG (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive Medicine Associates of New Jersey
  Basking Ridge, New Jersey, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• intrauterine injection of HCG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive & Genetic Hospital of CITIC-XIANGYA
  Changsha, Hunan, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HCG (drug)
• culture medium (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive & Genetic Hospital of CITIC-XIANGYA
  Changsha, Hunan, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human menopausal gonadotrophin (drug)
• hormone replacement therapy (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Reproductive & Genetic Hospital of CITIC-XIANGYA
  Changsha, Hunan, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Medical treatment (drug) — also listed as: Surgical treatment

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Maria Dolores Reguera Saborido
  Benguela, Angola
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dydrogesterone Tablets (drug)
• cetrorelix 0.25mg (drug)
• human menopausal gonadotropin (drug)
• triptorelin 0.1 mg (drug)
• human chorionic gonadotropin (drug)
• cryopreservation (procedure)
• Estradiol Valerate and progesterone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Recombinant Follicle Stimulating Hormone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of California, San Diego
  La Jolla, California, United States
  Site recruitment: Not reported